CD34 and retinal vascular occlusion: In a study from 2014, Park et al. [62] injected bone marrow stem cells (CD34+) into the vitreous, in various diseases leading to irreversible loss of vision (AMD two cases, retinitis pigmentosa one case, retinal vascular occlusion one case, and Stargardt two cases).